Kimberly Hess

447 total citations
18 papers, 290 citations indexed

About

Kimberly Hess is a scholar working on Public Health, Environmental and Occupational Health, Economics and Econometrics and Molecular Biology. According to data from OpenAlex, Kimberly Hess has authored 18 papers receiving a total of 290 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Public Health, Environmental and Occupational Health, 13 papers in Economics and Econometrics and 3 papers in Molecular Biology. Recurrent topics in Kimberly Hess's work include Pharmaceutical Economics and Policy (13 papers), Pharmaceutical Quality and Counterfeiting (13 papers) and Diverse Scientific Research Studies (3 papers). Kimberly Hess is often cited by papers focused on Pharmaceutical Economics and Policy (13 papers), Pharmaceutical Quality and Counterfeiting (13 papers) and Diverse Scientific Research Studies (3 papers). Kimberly Hess collaborates with scholars based in United States, United Kingdom and Canada. Kimberly Hess's co-authors include Roger Bate, Tracy Gosselin, Lorraine Mooney, Susan Schneider, Amir Attaran, Bibek Debroy, Paul Jensen, Richard Wang and John R. Talburt and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and The Lancet Infectious Diseases.

In The Last Decade

Kimberly Hess

17 papers receiving 259 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Kimberly Hess United States 7 189 139 47 35 34 18 290
András Fittler Hungary 12 221 1.2× 129 0.9× 21 0.4× 41 1.2× 22 0.6× 35 460
Céline Caillet United Kingdom 13 255 1.3× 156 1.1× 22 0.5× 8 0.2× 66 1.9× 31 414
Cécile Macé Switzerland 5 179 0.9× 197 1.4× 47 1.0× 6 0.2× 16 0.5× 7 331
Elisângela da Costa Lima Brazil 11 72 0.4× 43 0.3× 70 1.5× 15 0.4× 28 0.8× 46 379
Brenda Waning United States 8 84 0.4× 321 2.3× 132 2.8× 12 0.3× 11 0.3× 13 527
Kim Pauwels Belgium 9 48 0.3× 286 2.1× 55 1.2× 10 0.3× 11 0.3× 17 391
Pierre Claver Kayumba Rwanda 9 88 0.5× 69 0.5× 56 1.2× 6 0.2× 28 0.8× 19 269
Bill Shannon Ireland 9 77 0.4× 206 1.5× 117 2.5× 13 0.4× 32 0.9× 23 443
Caijun Yang China 8 49 0.3× 140 1.0× 33 0.7× 16 0.5× 6 0.2× 20 289
Tomasz Bochenek Poland 10 65 0.3× 200 1.4× 53 1.1× 7 0.2× 7 0.2× 28 366

Countries citing papers authored by Kimberly Hess

Since Specialization
Citations

This map shows the geographic impact of Kimberly Hess's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kimberly Hess with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kimberly Hess more than expected).

Fields of papers citing papers by Kimberly Hess

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kimberly Hess. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kimberly Hess. The network helps show where Kimberly Hess may publish in the future.

Co-authorship network of co-authors of Kimberly Hess

This figure shows the co-authorship network connecting the top 25 collaborators of Kimberly Hess. A scholar is included among the top collaborators of Kimberly Hess based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kimberly Hess. Kimberly Hess is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Bate, Roger, et al.. (2013). Substandard and falsified anti-tuberculosis drugs: a preliminary field analysis. The International Journal of Tuberculosis and Lung Disease. 17(3). 308–311. 3 indexed citations
2.
3.
4.
5.
Bate, Roger & Kimberly Hess. (2012). The role of pre-shipment batch testing in ensuring good medicine quality. PubMed. 3. 12–12. 6 indexed citations
6.
Schneider, Susan, Kimberly Hess, & Tracy Gosselin. (2011). Interventions to Promote Adherence With Oral Agents. Seminars in Oncology Nursing. 27(2). 133–141. 65 indexed citations
7.
Bate, Roger, et al.. (2011). The Global Fund's Malaria Medicine Subsidy: A Nice Idea with Nasty Implications. SSRN Electronic Journal. 4 indexed citations
8.
Bate, Roger, Lorraine Mooney, & Kimberly Hess. (2010). Medicine Registration and Medicine Quality: A Preliminary Analysis of Key Cities in Emerging Markets. SSRN Electronic Journal. 6 indexed citations
9.
Bate, Roger & Kimberly Hess. (2010). Anti-Malarial Drug Quality in Lagos and Accra - A Comparison of Various Quality Assessments. SSRN Electronic Journal. 4 indexed citations
10.
Bate, Roger, Kimberly Hess, & Lorraine Mooney. (2010). Antimalarial Medicine Diversion: Stock-Outs and Other Public Health Problems. SHILAP Revista de lepidopterología. 6 indexed citations
11.
Bate, Roger & Kimberly Hess. (2010). Assessing Website Pharmacy Drug Quality: Safer Than You Think?. PLoS ONE. 5(8). e12199–e12199. 20 indexed citations
12.
Bate, Roger & Kimberly Hess. (2010). Anti-malarial drug quality in Lagos and Accra - a comparison of various quality assessments. Malaria Journal. 9(1). 157–157. 43 indexed citations
13.
Bate, Roger, et al.. (2009). Pilot Study of Essential Drug Quality in Two Major Cities in India. SSRN Electronic Journal. 6 indexed citations
14.
Bate, Roger, et al.. (2009). Pilot study comparing technologies to test for substandard drugs in field settings. SSRN Electronic Journal. 35 indexed citations
15.
Bate, Roger, et al.. (2009). Pilot Study of Essential Drug Quality in Two Major Cities in India. PLoS ONE. 4(6). e6003–e6003. 62 indexed citations
16.
Bate, Roger, et al.. (2009). Physical and chemical stability of expired fixed dose combination artemether-lumefantrine in uncontrolled tropical conditions. Malaria Journal. 8(1). 33–33. 16 indexed citations
17.
Bate, Roger & Kimberly Hess. (2009). Affordable Medicines Facility for malaria. The Lancet Infectious Diseases. 9(7). 396–397. 6 indexed citations
18.
Talburt, John R., et al.. (2004). An Algebraic Approach to Quality Metrics for Customer Recognition Systems.. ICIQ. 234–247. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by András Fittler Breakdown of academic impact, for papers by Céline Caillet Breakdown of academic impact, for papers by Cécile Macé Breakdown of academic impact, for papers by Elisângela da Costa Lima Breakdown of academic impact, for papers by Brenda Waning Breakdown of academic impact, for papers by Kim Pauwels Breakdown of academic impact, for papers by Pierre Claver Kayumba Breakdown of academic impact, for papers by Bill Shannon Breakdown of academic impact, for papers by Caijun Yang Breakdown of academic impact, for papers by Tomasz Bochenek
Rankless by CCL
2026